In breast cancer cells such as MCF-7, RLN2 has been primarily shown to induce NO production by upregulating inducible nitric oxide synthase (iNOS), possibly to promote increased blood flow and angiogenesis in these cells [9,10]. This evidence concerns the gene NOS2 and breast cancer.